Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
310,006
Value
$155.4M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of TMO by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026310,006$155.4M0.1%−35,746−10.3%ReducedHolders
Q1 2026345,752$169.9M0.1%−14,742−4.1%ReducedHolders
Q4 2025360,494$208.9M0.2%−410,280−53.2%ReducedHolders
Q3 2025770,774$373.8M0.3%+337,008+77.7%AddedHolders
Q2 2025433,766$175.9M0.2%+43,051+11.0%AddedHolders
Q1 2025390,715$194.4M0.3%−27,650−6.6%ReducedHolders
Q4 2024418,365$217.6M0.3%+68,927+19.7%AddedHolders
Q3 2024349,438$201.4M0.3%+5,721+1.7%AddedHolders
Q2 2024343,717$190.1M0.3%−31,057−8.3%ReducedHolders
Q1 2024374,774$217.8M0.3%+22,557+6.4%AddedHolders
Q4 2023352,217$187.0M0.3%+339,013+2,567.5%AddedHolders
Q3 202313,204$6.68M<0.1%−1,954−12.9%ReducedHolders
Q2 202315,158$7.91M<0.1%+991+7.0%AddedHolders
Q1 202314,167$8.16M<0.1%+1,533+12.1%AddedHolders
Q4 202212,634$6.96M<0.1%−190−1.5%ReducedHolders
Q3 202212,824$6.50M<0.1%−333−2.5%ReducedHolders
Q2 202213,157$7.15M<0.1%−2,390−15.4%ReducedHolders
Q1 202215,547$9.18M<0.1%−1,470−8.6%ReducedHolders
Q4 202117,017$11.4M<0.1%−172,193−91.0%ReducedHolders
Q3 2021189,210$108.1M0.3%−5,431−2.8%ReducedHolders
Q2 2021194,641$98.2M0.2%+189,478+3,669.9%AddedHolders
Q1 20215,163$2.36M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.